
The Promising Clinical Trials in the Breakthrough T1D Pipeline
As the leading global funder of type 1 diabetes (T1D) research, Breakthrough T1D invests in the most promising research studies…

One Less Device: Combining CGM and Insulin Infusion
Breakthrough T1D is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and…

Why Does One Scientist Seek Cures for T1D? Answer: Family
Reza Abdi, M.D., has a reason to care about type 1 diabetes research—he has a father and a brother with…

Production of Insulin in People with Type 1 Diabetes
Sernova, a clinical-stage regenerative medicine company, has shown in its Breakthrough T1D-funded clinical trial that its cell replacement therapy, the…

This Stent is a Champion for Type 1 Diabetes Clinical Trials
Maribeth Stent was diagnosed with type 1 diabetes (T1D) in the fall of 1997. “It was right around my second…

Can Two Viral Drugs Halt Type 1 Diabetes?
Scientists in Norway are seeking participants for a clinical trial to see if a course of anti-viral treatment may stop…

Breakthrough T1D Innovative Clinical Trial Design Workshop
BMC Medicine 16: 29 (2018)

Triple Therapy in T1D: Breakthrough T1D Researchers Launch a Clinical Trial
Since its discovery nearly 100 years ago, insulin has been the only effective treatment for type 1 diabetes (T1D). Improvements…

Advancing the Cure with Type 1 Diabetes Clinical Trials
Breakthrough T1D funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people…

In First-In-Human Tests, New Artificial Pancreas System Smartphone App Shows Reliable Glucose Control
Artificial pancreas (AP) systems “close the loop” between continuous glucose monitors and insulin pumps using algorithms to manage insulin. Learn…